Exogenous soluble VEGF receptor-1 (sFlt-1) regulates Th1Th2 cytokine production from normal placental explants via intracellular calcium sVEGFR-1 (sFlt-1) regulates placental IL-10&TNF-

Hypertension in Pregnancy

Volumn 28, Issue 4, 2009, Pages 448-456

  Xu, Bei ^a   Thornton, Charlene ^b   Tooher, Jane ^b   Hennessy, Annemarie ^a,c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

BAPTA AM; IL 10; Placenta.; SVEGFR 1 (sFlt 1); TNF a

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GLUCOSE; INTERLEUKIN 10; SOLUBLE VASCULOTROPIN RECEPTOR 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1;

ARTICLE; CALCIUM CELL LEVEL; CLINICAL ARTICLE; CYTOKINE PRODUCTION; EXPLANT; FEMALE; HUMAN; PLACENTA DEVELOPMENT; PLACENTA VILLUS; PREECLAMPSIA; TH1 CELL; TH2 CELL;

CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; EGTAZIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GROWTH HORMONE; HUMANS; INTERLEUKIN-10; ORGAN CULTURE TECHNIQUES; PLACENTA; PLACENTAL HORMONES; PREGNANCY; PROTEIN ISOFORMS; STATISTICS, NONPARAMETRIC; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 70350322129     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641950902777721     Document Type: Article

References (33)

1. Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308:1592-1594.
2. Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 122:33-39.
3. Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005; 90:4895-4903.
4. Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649-658.
5. Polliotti BM, Fry AG, Saller DN, Mooney RA, Cox C, Miller RK. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 2003; 101:1266-1274.
6. Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, Waugh R, McKenzie P, Kirwan P, Hennessy A. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int 2007; 71:977-984.
7. Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response-a review. Placenta 2003; 24 Suppl A:S21-27.
8. Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996; 32:157-169.
9. Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL-10 in preeclampsia. J Immunol 1999; 163:3491-3495.
10. Orange S, Rasko JE, Thompson JF, Vaughan J, Olive E, Pedler M, Horvath JS, Hennessy A. Interleukin-10 regulates arterial pressure in early primate pregnancy. Cytokine 2005; 29:176-185.
11. Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59:161-173.
12. Turner MA, Shaikh SA, Greenwood SL. Secretion of interleukin-1beta and interleukin- 6 by fragments of term human placental villi: signalling pathways and effects of tumour necrosis factor alpha and mode of delivery. Placenta 2002; 23: 467-474.
13. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 1997; 82:1582-1588.
14. Xu B, Makris A, Thornton C, Ogle R, Horvath JS, Hennessy A. Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy. J Hypertens 2006; 24:915-922.
15. 2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes. Br J Pharmacol 2005; 145: 535-544.
16. Di Santo S, Malek A, Sager R, Andres AC, Schneider H. Trophoblast viability in perfused term placental tissue and explant cultures limited to 7-24 hours. Placenta 2003; 24:882-894.
17. Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683-765.
18. Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000; 47:87-103.
19. Naldini A, Pucci A, Bernini C, Carraro F. Regulation of angiogenesis by Th1- and Th2-type cytokines. Curr Pharm Des 2003; 9:511-519.
20. Hunt JS, Chen HL, Miller L. Tumor necrosis factors: pivotal components of pregnancy? Biol Reprod 1996; 54:554-562.
21. Beckmann I, Efraim SB, Vervoort M, Visser W, Wallenburg HC. Tumor necrosis factor-alpha in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women. Hypertens Pregnancy 2004; 23:319-329.
22. Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998; 40:102-111.
23. Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86:2505-2512.
24. Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004; 164:1049-1061.
25. Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004; 95:884-891.
26. Belkacemi L, Bedard I, Simoneau L, Lafond J. Calcium channels, transporters and exchangers in placenta: a review. Cell Calcium 2005; 37:1-8.
27. Rafiq K, Charitidou L, Bullens DM, Kasran A, Lorre K, Ceuppens J, van Gool SW. Regulation of the IL-10 production by human T cells. Scand J Immunol 2001; 53:139-147.
28. Crabtree GR. Calcium, calcineurin, and the control of transcription. J Biol Chem 2001; 276:2313-2316.
29. Mendez-Samperio P, Trejo A, Miranda E. Activation of ERK1/2 and TNF-alpha production are mediated by calcium/calmodulin, and PKA signaling pathways during Mycobacterium bovis infection. J Infect 2006; 52:147-153.
30. Krysiak O, Bretschneider A, Zhong E, Webb J, Hopp H, Verlohren S, Fuhr N, Lanowska M, Nonnenmacher A, Vetter R, Jankowski J, Paul M, Schonfelder G. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF. Circ Res 2005; 97:1253-1261.
31. Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 2004; 172:4618-4623.
32. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002; 8:831-840.
33. Lingen MW. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med 2001; 125:67-71.